NCT04405167 2025-10-07Tasquinimod for the Treatment of Relapsed or Refractory MyelomaUniversity of PennsylvaniaPhase 1 Terminated30 enrolled
NCT02396368 2015-11-20Radium-223Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Withdrawn